Pediatrix Medical Group, Inc.: stock overview

MDNYSEHealthcare · Services-Hospitals

Price

$31.30

November 13, 2026Market cap $2.4B

DCF calculator

What Ploutos Investor adds for Pediatrix Medical

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 10 fiscal years, from 2016
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

In short

Pediatrix Medical had revenue of $2.0B over the last 12 months and net income of $150M, a net margin of 7.7%. Revenue grew by 2.0% a year on average over the last 5 years. At $31.30 the shares trade at a P/E of 16.3, against a median of 15.3 over the last 4 fiscal years. It has net debt of $152M. It pays no dividend.

From its SEC filings (latest fiscal year to December 31, 2025) and the price of November 13, 2026.

Its SEC filings
Market cap
$2.4B
78.12M shares
P/E
16.3
Today16.3
Median15.3
Revenue, 12 months
$2.0B
+2.0% a year over 5 years
Net margin
7.7%
2025: 8.6%, above 88% of its industry

Worth knowing

What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.

3 fiscal years in figures

Each fiscal year's figures as the company filed them, and the share price at its end.

2023–2025 fiscal years

-2.0% a year over 2 years

  • 202510-K
    Revenue$1.9B
  • 202410-K
    Revenue$2.0B
  • 202310-K
    Revenue$2.0B

Fiscal years in figures

MD's revenue, profit, cash flow and dividend with each year-end price, from 2016 to 2022, 7 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

Key figures

The company's current figures in five groups. Each term is explained behind its ⓘ.

Valuation

Market cap 3-year median: $1.1B
$2.4B
Enterprise value 
$2.6B
P/E 
16.3
EV / EBIT 
12.2
EV / Revenue 
1.3
P/B 3-year median: 1.5
2.9
FCF yield 3-year median: 14.2%
8.6%
Earnings yield 3-year median: 7.8%
6.1%

Profitability

Operating margin 
10.9%
Net margin 3-year median: -3.0%
7.7%
ROIC 
10.7%
ROIC, 5-year average 
5.0%
ROE 
17.2%

Growth

Revenue, yearly change 
-4.9%
EPS, yearly change 
–
FCF, yearly change 
+36.9%
Revenue, average a year 
+2.0%

The yearly change compares FY2025 with FY2024.

Balance sheet

Cash 
$426M
Total debt 
$612M
Of which operating leases 
$34M
Net debt 
$152M
Net debt / EBITDA 
0.7x
Interest cover 
6.4x
Current ratio 
1.28

Balance sheet of September 30, 2026.

Returns to shareholders

Dividend yield 
0.00%
Buybacks 
3.54%
Total returned 
3.54%
Shares, yearly change 
-3.3%
Valuation against its own pastEach fiscal year's P/E, P/FCF and P/B beside today's, and the DCF calculator for the company.Valuation

Against its industry

Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 80).

Operating margin

10.9%

Above 80% of the 62 companies in its industry, and 66% of all.

Net margin

8.6%

Above 88% of the 68 companies in its industry, and 62% of all.

ROE

19.1%

Above 85% of the 58 companies in its industry, and 83% of all.

ROA

7.4%

Above 82% of the 69 companies in its industry, and 81% of all.

Revenue growth

-4.9%

Above 7% of the 68 companies in its industry, and 17% of all.

From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.

The company at the SEC

How it is registered and when its fiscal year ends.

Name at the SEC
Pediatrix Medical Group, Inc.
CIK
893949
Exchange
NYSE
Industry (SIC)
8060 · Services-Hospitals
Fiscal year ends
December 31
Latest annual report
December 31, 2025
Reporting currency
USD
Shares
78.12M

Other companies: Healthcare

The largest companies of the same sector, each with its own page.

The Healthcare sectorAll companies

The full analysis

What do Pediatrix Medical's filings show?

These are Pediatrix Medical's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about MD

Didn't find what you were looking for?

Ask us
What is MD's market cap?

Pediatrix Medical Group, Inc.'s market cap is $2.4B, at a price of $31.30 on November 13, 2026 and 78.12M shares.

What is MD's P/E?

MD's P/E is 16.3, on earnings per share of $1.84 over the last 12 months. The median over the last 4 fiscal years was 15.3.

How much revenue does MD have?

Pediatrix Medical had revenue of $2.0B over the last 12 months. Over the last 5 years it changed by +2.0% a year on average.

Does MD pay a dividend?

No. Pediatrix Medical paid no regular dividend over the last 12 months.

Where do the figures come from?

From Pediatrix Medical Group, Inc.'s SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.